Advertisement
Screener

Taysha Gene Therapies, Inc. (TSHA) Stock Issued During Period, Value, New Issues

Taysha Gene Therapies, Inc. Stock Issued During Period, Value, New Issues

New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.

  • Taysha Gene Therapies, Inc. stock issued during period, value, new issues for the quarter ending 2022-09-30 was $0.00.
  • Taysha Gene Therapies, Inc. stock issued during period, value, new issues for the quarter ending 2022-06-30 was $11.61M.
  • Taysha Gene Therapies, Inc. stock issued during period, value, new issues for the quarter ending 2020-12-31 was -$35.00K.
  • Taysha Gene Therapies, Inc. stock issued during period, value, new issues for the quarter ending 2020-09-30 was $165.89M.
  • Taysha Gene Therapies, Inc. stock issued during period, value, new issues for fiscal 2020 was $165.85M.
Period endStock Issued During Period, Value, New Issues 3 monthStock Issued During Period, Value, New Issues 12 month
2022-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14
2022-06-30$11.61M
10-Q · filed 2023-08-14
2020-12-31-$35.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31
$165.85M
10-K · filed 2022-03-31
2020-09-30$165.89M
10-Q · filed 2021-11-10

Similar stocks

Stock NameCountryMarket CapPE Ratio
Immunocore Holdings plc (IMCR)$1.613B-90.43
Inhibrx Biosciences, Inc. (INBX)United States$1.477B-10.08
Maze Therapeutics, Inc. (MAZE)United States$1.457B-12.40
Hemab Therapeutics Holdings, Inc. (COAG)United States$1.672B
NOVAVAX INC (NVAX)United States$1.748B-6.26
Vir Biotechnology, Inc. (VIR)United States$1.814B-6.85
Replimune Group, Inc. (REPL)United States$1.186B-3.13
Vericel Corp (VCEL)United States$2.011B93.97
Vor Biopharma Inc. (VOR)United States$1.091B1.60
MeiraGTx Holdings plc (MGTX)United States$1.061B16.10